EcoDrugPlus

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSMLUG00000012720
Gene Symbol: IDO1
2 Cross references
98 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSMLUG00000002199
Gene Symbol: IMPDH1
2 Cross references
330 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSMLUG00000013965
Gene Symbol: IMPDH2
4 Cross references
200 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSMLUG00000017391
Gene Symbol: INPP5D
2 Cross references
213 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSMLUG00000017190
Gene Symbol: IGF1R
2 Cross references
274 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSMLUG00000013806
Gene Symbol: INSR
2 Cross references
288 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSMLUG00000014215
Gene Symbol: ITGA4
2 Cross references
236 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSMLUG00000012946
Gene Symbol: ITGA5
2 Cross references
269 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSMLUG00000007682
Gene Symbol: ITGAV
2 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSMLUG00000017570
Gene Symbol: ITGB1
2 Cross references
298 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSMLUG00000030451
Gene Symbol: ITGB3
2 Cross references
265 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSMLUG00000002372
Gene Symbol: ITGB5
2 Cross references
210 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).